ALEXANDRIA, Va., July 14 -- United States Patent no. 12,680,108, issued on July 14, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Miniaturized dystrophins and uses thereof" was invented by Glen Banks (Yardley, Pa.), Jonathan Harry Davis (Madison, Wis.) and Paul Charles Levesque (Yardley, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed."

The patent was filed on Oct. 24, 2019, under Application No. 17/288,029.

*For further information, including im...